Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Innovators: Drik, LLC

Get in Touch

By Brian Brus

Courtesy of The Journal Record

OKLAHOMA CITY – Rapid advances in chemical technologies have created a niche market need for companies such as Oklahoma City-based Drik LLC, founder and Chief Executive Kumar Sripathirathan said.

The toxic impacts of less than one-tenth of the tens of thousands of regulated chemicals in the market are clearly known, Sripathirathan said. So the earlier that a company can determine drug potentials, the better it will be positioned to prioritize resource allocation to deliver treatments for disease. Such companies are the core of Drik’s consultancy business, as it caters to a wide range of interests involved in not only pharmaceuticals, but also consumer products such as cosmetics.

Dr. Kumar Sripathirathan, Drik LLC founder and CEO/Journal Record photo by Brent FuchsDrik offers slice culture testing, which Sripathirathan said is superior to the cell culture testing that many toxicology labs elsewhere perform. In addition to the slice cultures being more accurate, they also last longer, remaining viable for more than a month instead of the days-long life span of cell cultures. The company also provides customized, cost-effective studies that produce results quickly, appropriate for the Environmental Protection Agency’s Good Laboratory Practice standards.

As the biotech industry looks to cut costs, lean business models are needed to provide value-enhanced services with reduced overhead costs, Sripathirathan said. Drik is a good example of a symbiotic business partner, paring the time and money typically necessary for toxicology audits.

“We work with some of the strongest talents in the state, which enhances our work,” Sripathirathan said. He added that his company works with as many reliable, local vendors as possible who help reduce costs and increase economic vitality in the state.

Drik, the state’s first commercial toxicology lab, is housed at the Presbyterian Health Foundation incubator in Oklahoma City. The company is well-funded, he said, and enjoys its relationships with other companies at the incubator.

“It makes things easier for one-on-one work,” he said.

Sripathirathan said the company has identified several companies, university research centers and other agencies in neighboring states that are likely candidates for Drik’s toxicology services, and is actively reaching out to them for growth.

Click here to read the article at the Journal Record website.

Author

  • admin admin

More News

Loading...
Black doctor smiling with stethoscope
Blog, i2E
02.09.23

Titan Intake Automates Patient Referrals to Accelerate Care

Read more
man and woman reviewing paperwork at a table
Blog, i2E, News
01.10.23

Stories of Oklahoma Innovation: Building a Startup

Read more
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E